BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 30593086)

  • 1. Characteristics and Management of Patients with Venous Thromboembolism: The GARFIELD-VTE Registry.
    Ageno W; Haas S; Weitz JI; Goldhaber SZ; Turpie AGG; Goto S; Angchaisuksiri P; Nielsen JD; Kayani G; Pieper KS; Schellong S; Bounameaux H; Mantovani LG; Prandoni P; Kakkar AK;
    Thromb Haemost; 2019 Feb; 119(2):319-327. PubMed ID: 30593086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD-VTE patients.
    Haas S; Ageno W; Weitz JI; Goldhaber SZ; Turpie AGG; Goto S; Angchaisuksiri P; Dalsgaard Nielsen J; Kayani G; Zaghdoun A; Farjat AE; Schellong S; Bounameaux H; Mantovani LG; Prandoni P; Kakkar AK
    J Thromb Haemost; 2019 Oct; 17(10):1694-1706. PubMed ID: 31220403
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global Risk Profile Verification in Patients with Venous Thromboembolism (GRIP VTE) in 5 Gulf countries.
    Al Sayegh F; Almahmeed W; Al Humood S; Marashi M; Bahr A; Al Mahdi H; Bakir S; Al Farhan M
    Clin Appl Thromb Hemost; 2009; 15(3):289-96. PubMed ID: 18400764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparing U.S. and Canadian treatment patterns on venous thromboembolism outcomes in the GARFIELD-VTE registry.
    Chen AC; Rao AS; Oropallo A; Goldhaber SZ; Fluharty ME; Maheshwari U; Carrier M; Turpie AGG; Pieper K; Kayani G; Kakkar AK;
    Thromb Res; 2023 Dec; 232():123-132. PubMed ID: 37976732
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The management of acute venous thromboembolism in clinical practice. Results from the European PREFER in VTE Registry.
    Cohen AT; Gitt AK; Bauersachs R; Fronk EM; Laeis P; Mismetti P; Monreal M; Willich SN; Bramlage P; Agnelli G; Prefer In Vte Scientific Steering Committee And The Prefer In Vte Investigators OBOT
    Thromb Haemost; 2017 Jun; 117(7):1326-1337. PubMed ID: 28405675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global Anticoagulant Registry in the Field - Venous Thromboembolism (GARFIELD-VTE). Rationale and design.
    Weitz JI; Haas S; Ageno W; Angchaisuksiri P; Bounameaux H; Nielsen JD; Goldhaber SZ; Goto S; Kayani G; Mantovani L; Prandoni P; Schellong S; Turpie AG; Kakkar AK
    Thromb Haemost; 2016 Nov; 116(6):1172-1179. PubMed ID: 27656711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrence of venous thromboembolism in patients with recent gestational deep vein thrombosis or pulmonary embolism: Findings from the RIETE Registry.
    Barillari G; Londero AP; Brenner B; Nauffal D; Muñoz-Torrero JF; Del Molino F; Moustafa F; Madridano O; Martín-Martos F; Monreal M;
    Eur J Intern Med; 2016 Jul; 32():53-9. PubMed ID: 26972931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 36-month clinical outcomes of patients with venous thromboembolism: GARFIELD-VTE.
    Turpie AGG; Farjat AE; Haas S; Ageno W; Weitz JI; Goldhaber SZ; Goto S; Angchaisuksiri P; Kayani G; Lopes RD; Chiang CE; Gibbs H; Tse E; Verhamme P; Ten Cate H; Muntaner J; Schellong S; Bounameaux H; Prandoni P; Maheshwari U; Kakkar AK;
    Thromb Res; 2023 Feb; 222():31-39. PubMed ID: 36565677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of patients with venous thromboembolism in Italy: insights from the PREFER in VTE registry.
    Guercini F; Mommi V; Camporese G; Tonello C; Imberti D; Benedetti R; De Bartolomeo G; Di Lecce L; Romeo F; Agnelli G
    Intern Emerg Med; 2016 Dec; 11(8):1095-1102. PubMed ID: 27448310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Declining Long-term Risk of Adverse Events after First-time Community-presenting Venous Thromboembolism: The Population-based Worcester VTE Study (1999 to 2009).
    Huang W; Goldberg RJ; Cohen AT; Anderson FA; Kiefe CI; Gore JM; Spencer FA
    Thromb Res; 2015 Jun; 135(6):1100-6. PubMed ID: 25921936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE.
    Weitz JI; Haas S; Ageno W; Goldhaber SZ; Turpie AGG; Goto S; Angchaisuksiri P; Nielsen JD; Kayani G; Farjat AE; Schellong S; Bounameaux H; Mantovani LG; Prandoni P; Kakkar AK;
    J Thromb Thrombolysis; 2020 Aug; 50(2):267-277. PubMed ID: 32583306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The management and outcome of acute venous thromboembolism: a prospective registry including 4011 patients.
    Arcelus JI; Caprini JA; Monreal M; Suárez C; González-Fajardo J
    J Vasc Surg; 2003 Nov; 38(5):916-22. PubMed ID: 14603194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment patterns of venous thromboembolism in a real-world population: the Q-VTE study cohort.
    Tagalakis V; Patenaude V; Kahn SR; Suissa S
    Thromb Res; 2014 Oct; 134(4):795-802. PubMed ID: 25135794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and characteristics of venous thromboembolic disease during pregnancy and the postnatal period: a contemporary series.
    O'Connor DJ; Scher LA; Gargiulo NJ; Jang J; Suggs WD; Lipsitz EC
    Ann Vasc Surg; 2011 Jan; 25(1):9-14. PubMed ID: 20800436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differences in duration of anticoagulation after pulmonary embolism and deep vein thrombosis: Findings from the SWIss Venous ThromboEmbolism Registry (SWIVTER).
    Wenger N; Sebastian T; Beer JH; Mazzolai L; Aujesky D; Hayoz D; Engelberger RP; Korte W; Voci D; Kucher N; Barco S; Spirk D
    Thromb Res; 2022 Dec; 220():65-71. PubMed ID: 36272334
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes Associated With Inferior Vena Cava Filters Among Patients With Thromboembolic Recurrence During Anticoagulant Therapy.
    Mellado M; Pijoan JI; Jiménez D; Muriel A; Aujesky D; Bertoletti L; Decousus H; Barrios D; Clará A; Yusen RD; Monreal M;
    JACC Cardiovasc Interv; 2016 Dec; 9(23):2440-2448. PubMed ID: 27838262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rationale and design of three observational, prospective cohort studies including biobanking to evaluate and improve diagnostics, management strategies and risk stratification in venous thromboembolism: the VTEval Project.
    Frank B; Ariza L; Lamparter H; Grossmann V; Prochaska JH; Ullmann A; Kindler F; Weisser G; Walter U; Lackner KJ; Espinola-Klein C; Münzel T; Konstantinides SV; Wild PS;
    BMJ Open; 2015 Jul; 5(7):e008157. PubMed ID: 26133379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Venous thromboembolism in centenarians: Findings from the RIETE registry.
    Lacruz B; Tiberio G; Núñez MJ; López-Jiménez L; Riera-Mestre A; Tiraferri E; Verhamme P; Mazzolai L; González J; Monreal M;
    Eur J Intern Med; 2016 Dec; 36():62-66. PubMed ID: 27495947
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale, Design and Methodology of the Computerized Registry of Patients with Venous Thromboembolism (RIETE).
    Bikdeli B; Jimenez D; Hawkins M; Ortíz S; Prandoni P; Brenner B; Decousus H; Masoudi FA; Trujillo-Santos J; Krumholz HM; Monreal M;
    Thromb Haemost; 2018 Jan; 118(1):214-224. PubMed ID: 29304541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous Thromboembolism Recurrence in Latvian Population: Single University Hospital Data.
    Ģībietis V; Kigitoviča D; Strautmane S; Meilande K; Kalējs VR; Zaičenko A; Maķe K; Lejnieks A; Skride A
    Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31438542
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 21.